Increasing Investments to Help Market Development

There are several factors that are responsible for the overall development of the global polymerase chain reaction (PCR) market. One of the key development factors for the global market has been increasing investments in the activities of research and development. In addition to this, emergence of digital polymerase chain reaction (PCR) technologies have become highly useful for cancer diagnosis as well treatment. This too has emerged as a key driving factor for the development of the global market. Furthermore, innovations and developments in pharmacogenomics and growing trend of self-diagnosis of disorders as a preventive measure are also expected to work in favor of the growth of the global polymerase chain reaction (PCR) market in the coming years of the forecast period. In recent years, the activities of research and development have considerably increased in the field of forensic science, genetic engineering, and advanced molecular biology. This too has worked in favor of the development of the global polymerase chain reaction (PCR) market.

However, there are a few factors that are projected to impede the development of the global polymerase chain reaction (PCR) market in the coming years. These challenges are projected to stop the market from reaching its full potential. One of the key restraining factors for the market development has been the emergence of alternative technologies. Some of the new and upcoming alternative technologies are next gen sequencing. In addition to this, high costs associated with some of the prominent polymerase chain reaction (PCR) technologies are also projected to impede the growth of the market in the near future.

polymerase-chain-reaction-market.jpg

The global polymerase chain reaction (PCR) market is primarily segmented based on type of product and end user. Based on the type of product, the global market is mainly segmented into consumables, reagents, and instruments. Among these, the segment of reagents has been the most dominant one in terms of value. This dominance of the segment is due to its high levels of consumption. This segment is expected to witness a promising CAGR in the coming years of the forecast period because of the rising innovation in the field of specificity of reagents. In addition to this, large scale availability of different types of tests which need different types of reagents, increasing geriatric population, growing prevalence of infectious diseases, and increasing demand for innovation in specificity of reagents are some of the other factors helping to drive overall growth of the reagent segment.

The segment of instruments is further segmented into digital polymerase chain reaction (PCR) systems, RT PCR systems, and standard polymerase chain reaction (PCR) systems. Of these, the sub segment of the RT polymerase chain reaction (PCR) is projected to account for a greater chunk in the global market in the coming years of the forecast period. However, the sub segment of digital polymerase chain reaction (PCR) is expected to witness a highly promising CAGR in the near future.

Diagnostic Labs and Hospitals to Witness Promising Growth

Based on end user, the global market for polymerase chain reaction (PCR) is segmented into research and academic organizations, clinical diagnostics hospitals and labs, and pharmaceutical and biotechnology industries. Among these, the segment of pharmaceutical and biotechnology industries account for a larger share in the global market. Constant advancements and developments in the fields of biotechnology as well pharmaceutical is projected to be the key driving factor for the development of the segment. These developments are also helping researchers and scientists to determine new gene expressions, genetic variations, and novel genes in the tissue of an organism.

On the other hand, the segment of clinical diagnostics labs and hospitals is expected to witness a highly promising CAGR in the coming years of the forecast period. This growth of the segment is primarily driven due to the increasing prevalence of cancer and other prominent infectious disorders across the globe.

North America to Continue Leading Global Market

Based on geography, the global polymerase chain reaction (PCR) market is segmented into five key regions viz. North America, Latin America, Middle East and Africa, Europe, and Asia Pacific. Among these, the regional segment of North America has been the most dominant one in recent years. The growth of the regional market can be attributed to the matured and developed healthcare infrastructure present in North America. In addition to this, in recent years, there has been a growing advent of automated polymerase chain reaction (PCR) instruments. This, coupled with improved spending power and affordability of these instruments have also helped in improving the development of the regional market.

Major players operating in the global PCR market include Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies. Key players are expanding their product portfolio through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical and biotechnology companies and by offering technologically advanced products.

Polymerase Chain Reaction (PCR) Market - Overview

This comprehensive report by Transparency Market Research analyzes the global PCR market for the period between 2018 and 2026. An in-depth and unbiased market assessment has been made, which offers readers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development of diagnostic reagents, instruments, and consumables; PCR service providers, research and development laboratories, clinical diagnostic laboratories, and academic and research institutes involved in the clinical diagnosis and research activities related to PCR technology.

The global PCR market has been studied for the forecast period from 2018 to 2026. For research, 2017 has been considered as the base year and 2016 as the historical year. The global PCR market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global PCR market for 2017. The report also provides detail company profiles of emerging market players operating in the global PCR market.

The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the global PCR market. These factors are likely to aid stakeholders establish a strong foothold in the global PCR market. Furthermore, the market overview section comprises key industry events, product portfolio overview of leading players and market attractiveness analysis in the global PCR market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

Scope

The global PCR market has been segmented based product and end-user. In terms of product, the global PCR market has been segmented into instruments, reagents, and consumables. The instruments segment has been further sub-segmented into standard PCR, RT PCR, and digital PCR. In terms of end-user, the global PCR market has been categorized into pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, academic and research organizations, and others.

In terms of geography, the global PCR market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Australia & New Zealand, has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the PCR market in various regions has been provided in this section.

The report provides a detailed outline/blueprint of the PCR market globally that is expected to assist new companies establish their presence and market players in expanding their share in the market. The report concludes with the company profile section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments for market players.

Competitive landscape

Major players operating in the global PCR market include Bio-Rad Laboratories, Inc., QIAGEN N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc. Becton, Dickinson and Company, Abbott, Siemens Healthcare GmbH (Siemens AG), bioMérieux SA, Danaher Corporation, and Agilent Technologies.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The global PCR market has been segmented into:

Product

  • Instruments
    • Standard PCR
    • RT PCR
    • Digital PCR
  • Reagents
  • Consumables

End-user

  • Pharmaceutical and Biotechnology Industries
  • Clinical Diagnostics Labs and Hospitals
  • Academic and Research Organizations
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Rest of the World

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global PCR Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
            4.3.4. Trends
     4.4. Global PCR Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis

5. Market Outlook
     5.1. Product Portfolio Analysis, by Key Players
     5.2. Distributor Analysis, by Key Players
     5.3. End-user Expectations from PCR Reagents & Instruments Manufacturers
     5.4. Market Value Share Analysis (%): by PCR Technology
     5.5 Clinical Diagnostic PCR Value Share (%) by Type of Diseases/Disorder

6. Global PCR Market Analysis and Forecast, by Product
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast, by Product, 2016–2026
            6.3.1. Instruments
                     6.3.1.1. Standard PCR Systems
                     6.3.1.2. RT PCR Systems
                     6.3.1.3. Digital PCR Systems
            6.3.2. Reagents
            6.3.3. Consumables
     6.4. Market Attractiveness, by Product

7. Global PCR Market Analysis and Forecast, by End-user
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast, by End-user, 2016–2026
            7.3.1. Pharmaceutical and Biotechnology Industries
            7.3.2. Clinical Diagnostics Labs and Hospitals
            7.3.3. Academic and Research Organizations
            7.3.4. Others
     7.4. Market Attractiveness, by End-user

8. Global PCR Market Analysis and Forecast, by Region
     8.1. Key Findings
     8.2. Market Value Forecast, by Region
            8.2.1. North America
            8.2.2. Europe
            8.2.3. Asia Pacific
            8.2.4. Rest of the World
     8.3. Market Attractiveness, by Country/Region

9. North America PCR Market Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
     9.2. Market Value Forecast, by Product, 2016–2026
            9.2.1. Instruments
                     9.2.1.1. Standard PCR Systems
                     9.2.1.2. RT PCR Systems
                     9.2.1.3. Digital PCR Systems
            9.2.2. Reagents
            9.2.3. Consumables
     9.3. Market Value Forecast, by End-user, 2016–2026
            9.3.1. Pharmaceutical and Biotechnology Industries
            9.3.2. Clinical Diagnostics Labs and Hospitals
            9.3.3. Academic and Research Organizations
            9.3.4. Others
     9.4. Market Value Forecast, by Country, 2016–2026
            9.4.1. U.S.
            9.4.2. Canada
     9.5. Market Attractiveness Analysis
            9.5.1. By Product
            9.5.2. By End-user
            9.5.3. By Country

10. Europe PCR Market Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Market Value Forecast, by Product, 2016–2026
            10.2.1. Instruments
                     10.2.1.1. Standard PCR Systems
                     10.2.1.2. RT PCR Systems
                     10.2.1.3. Digital PCR Systems
            10.2.2. Reagents
            10.2.3. Consumables
     10.3. Market Value Forecast, by End-user, 2016–2026
            10.3.1. Pharmaceutical and Biotechnology Industries
            10.3.2. Clinical Diagnostics Labs and Hospitals
            10.3.3. Academic and Research Organizations
            10.3.4. Others
     10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
            10.4.1. Germany
            10.4.2. U.K.
            10.4.3. France
            10.4.4. Spain
            10.4.5. Italy
            10.4.6. Rest of Europe
     10.5. Market Attractiveness Analysis
            10.5.1. By Product
            10.5.2. By End-user
            10.5.3. By Country/Sub-region

11. Asia Pacific PCR Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Market Value Forecast, by Product, 2016–2026
            11.2.1. Instruments
                     11.2.1.1. Standard PCR Systems
                     11.2.1.2. RT PCR Systems
                     11.2.1.3. Digital PCR Systems
            11.2.2. Reagents
            11.2.3. Consumables
     11.3. Market Value Forecast, by End-user, 2016–2026
            11.3.1. Pharmaceutical and Biotechnology Industries
            11.3.2. Clinical Diagnostics Labs and Hospitals
            11.3.3. Academic and Research Organizations
            11.3.4. Others
     11.4. Market Value Forecast, by Country/Sub-region, 2016–2026
            11.4.1. China
            11.4.2. Japan
            11.4.3. India
            11.4.4. Australia & New Zealand
            11.4.5. Rest of Asia Pacific
     11.5. Market Attractiveness Analysis
            11.5.1. by Product
            11.5.2. by End-user
            11.5.3. by Country/Sub-region

12. Rest of the World PCR Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Market Value Forecast, by Product, 2016–2026
            12.2.1. Instruments
                     12.2.1.1. Standard PCR Systems
                     12.2.1.2. RT PCR Systems
                     12.2.1.3. Digital PCR Systems
            12.2.2. Reagents
            12.2.3. Consumables
     12.3. Market Value Forecast, by End-user, 2016–2026
            12.3.1. Pharmaceutical and Biotechnology Industries
            12.3.2. Clinical Diagnostics Labs and Hospitals
            12.3.3. Academic and Research Organizations
            12.3.4. Others
     12.4. Market Attractiveness Analysis
            12.4.1. by Product
            12.4.2. by End-user

13. Competition Landscape
     13.1. Market Player – Competition Matrix Competition Matrix (by Tier and Size of Companies)
     13.2. Market Share Analysis by Company (2017)
     13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            13.3.1. Bio-Rad Laboratories, Inc.
                     13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.1.2. Product Portfolio
                     13.3.1.3. SWOT Analysis
                     13.3.1.4. Financial Overview
                     13.3.1.5. Strategic Overview
            13.3.2. Qiagen N.V.
                     13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.2.2. Product Portfolio
                     13.3.2.3. SWOT Analysis
                     13.3.2.4. Financial Overview
                     13.3.2.5. Strategic Overview
            13.3.3. F. Hoffmann-La Roche AG
                     13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.3.2. Product Portfolio
                     13.3.3.3. SWOT Analysis
                     13.3.3.4. Financial Overview
                     13.3.3.5. Strategic Overview
            13.3.4. Thermo Fisher Scientific, Inc.
                     13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.4.2. Product Portfolio
                     13.3.4.3. SWOT Analysis
                     13.3.4.4. Financial Overview
                     13.3.4.5. Strategic Overview
            13.3.5. Becton, Dickinson and Company
                     13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.5.2. Product Portfolio
                     13.3.5.3. SWOT Analysis
                     13.3.5.4. Financial Overview
                     13.3.5.5. Strategic Overview
            13.3.6. Abbott
                     13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.6.2. Product Portfolio
                     13.3.6.3. SWOT Analysis
                     13.3.6.4. Financial Overview
                     13.3.6.5. Strategic Overview
            13.3.7. Siemens Healthcare GmbH (Siemens AG)
                     13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.7.2. Product Portfolio
                     13.3.7.3. SWOT Analysis
                     13.3.7.4. Financial Overview
                     13.3.7.5. Strategic Overview
            13.3.8. BioMérieux SA
                     13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.8.2. Product Portfolio
                     13.3.8.3. SWOT Analysis
                     13.3.8.4. Financial Overview
                     13.3.8.5. Strategic Overview
            13.3.9. Danaher Corporation
                     13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.9.2. Product Portfolio
                     13.3.9.3. SWOT Analysis
                     13.3.9.4. Financial Overview
                     13.3.9.5. Strategic Overview
            13.3.10. Agilent Technologies
                     13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     13.3.10.2. Product Portfolio
                     13.3.10.3. SWOT Analysis
                     13.3.10.4. Financial Overview
                     13.3.10.5. Strategic Overview

List of Tables

Table 01: Global PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 03: Global PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 04: Global PCR Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America PCR Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 07: North America PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 08: North America PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 09: U.S. PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 10: U.S. PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Canada PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 12: Canada PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Europe PCR Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Europe PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 15: Europe PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 16: Europe PCR Market Size (US$ Mn) Forecast, by Industry, 2016–2026
Table 17: Germany PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 18: Germany PCR Market Size (US$ Mn) Forecast, of Industry, 2016–2026
Table 19: France PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 20: France PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 21: Italy PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Italy PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 23: U.K. PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 24: U.K. PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 25: Russia PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 26: Russia PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 27: Spain PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 28: Spain PCR Market Size (US$ Mn) Forecast, Industry, 2016–2026
Table 29: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 31: Asia Pacific PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 32: Asia Pacific PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 33: China PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 34: China PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 35: India PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 36: India PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 37: Japan PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 39: Japan PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 40: Australia & New Zealand PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 41: Australia & New Zealand PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 42: Rest of the World PCR Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 43: Rest of the World PCR Market Size (US$ Mn) Forecast, by Instruments, 2016–2026
Table 44: Rest of the World PCR Market Size (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures

Figure 01: Global PCR Market Snapshot
Figure 02: Global PCR Market Size (US$ Mn) Forecast, 2016–2026
Figure 04: Global PCR Market Value Share (%), by End-user (2017)
Figure 05: Global PCR Market Value Share (%), by Region (2017)
Figure 03: Global PCR Market Value Share (%), by Product (2017)
Figure 06: Global PCR Market Value Share (%), by Product, 2017 and 2026
Figure 07: Global PCR Market Attractiveness, by Product, 2018–2026
Figure 08: Global PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Instruments Method, 2016–2026
Figure 09: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reagents Method, 2016–2026
Figure 10: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Consumables Method, 2016–2026
Figure 11: Global PCR Market Value Share (%), by End-user, 2017 and 2016
Figure 12: Global PCR Market Value Share (%), by End-user, 2017 and 2016
Figure 13: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Pharmaceutical & Biotechnology Industries, 2018–2026
Figure 14: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Clinical Diagnostics Labs and Hospitals, 2018–2026
Figure 15: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Academic and Research Organizations, 2018–2026
Figure 16: Global PCR Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2018–2026
Figure 17: Global PCR Market Attractiveness, by Region, 2018–2026
Figure 18: Global PCR Market Value Share (%), by Region, 2017 and 2016
Figure 19: North America PCR Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 20: North America PCR Market Value Share, by Country, 2017 and 2026
Figure 21: North America PCR Market Attractiveness, by Country, 2018–2026
Figure 22: North America PCR Market Value Share (%), by Product, 2017 and 2026
Figure 23: North America PCR Market Attractiveness, by Product, 2018–2026
Figure 24: North America PCR Market Value Share (%), by End-user, 2017 and 2026
Figure 25: North America PCR Market Attractiveness, by End-user, 2018–2026
Figure 26: Europe PCR Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 27: Europe PCR Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 28: Europe PCR Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 29: Europe PCR Market Value Share (%), by Product, 2017 and 2026
Figure 30: Europe PCR Market Attractiveness, by Product, 2018 and 2026
Figure 31: Europe PCR Market Value Share (%), by Industry, 2017 and 2026
Figure 32: Europe PCR Market Attractiveness, by Industry, 2018-2026
Figure 33: Asia Pacific PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 34: Asia Pacific PCR Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 35: Asia Pacific PCR Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 36: Asia Pacific PCR Market Value Share (%), by Product, 2017 and 2026
Figure 37: Asia Pacific PCR Market Attractiveness, by Product, 2018–2026
Figure 38: Asia Pacific PCR Market Value Share (%), by End-user, 2017 and 2026
Figure 39: Asia Pacific PCR Market Attractiveness, by End-user, 2018–2026
Figure 40: Rest of the World PCR Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 41: Rest of the World Mexico PCR Market Value Share (%), by Product, 2017 and 2026
Figure 42: Rest of the World Mexico PCR Market Attractiveness, by Product, 2018–2026
Figure 43: Rest of the World Mexico PCR Market Value Share (%), by End-user, 2017 and 2026
Figure 44: Rest of the World Mexico PCR Market Attractiveness, by End-user, 2018–2026
Figure 45: Company Share Analysis (%), 2017 
Figure 46 Bio-Rad Laboratories, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 47: Bio-Rad Laboratories, Inc. Breakdown of Net Sales, by Region, 2017
Figure 48: Bio-Rad Laboratories, Inc.  Breakdown of Net Sales, by Business Segment, 2017
Figure 49: Qiagen N.V. Breakdown of Net Sales, by Product Category, 2017
Figure 50: Qiagen N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 51: Qiagen N.V. Breakdown of Net Sales, by Region, 2017
Figure 52: F. Hoffmann-La Roche AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 53: F. Hoffmann-La Roche AG R&D Expenses, 2016–2017
Figure 54: F. Hoffmann-La Roche AG Breakdown of Net Sales, by Business Division, 2017
Figure 55: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Segment), by Region, 2017
Figure 56: Thermo Fisher Scientific, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 57: Thermo Fisher Scientific, Inc. R & D Expenses, 2015-2017
Figure 58: Thermo Fisher Scientific, Inc. Breakdown of Net Sales, by Region, 2017
Figure 59: Thermo Fisher Scientific, Inc.  Breakdown of Net Sales, by Business Segment, 2017
Figure 60: Becton, Dickinson and Company Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 61: Becton, Dickinson and Company R&D Intensity and Sales & Marketing Intensity – Company Level, (US$ Mn), 2016–2017
Figure 62: Becton, Dickinson and Company Breakdown of Net Sales, by Region, 2017
Figure 63: Becton, Dickinson and Company Breakdown of Net Sales, by Business Segment, 2017
Figure 64: Abbott Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 65: Abbott R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 66: Abbott Breakdown of Net Sales, by Segment, 2017
Figure 67: Abbott Breakdown of Net Sales (%), by Country, 2017
Figure 68: Siemens Healthcare GmbH Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 69: Siemens Healthcare GmbH Diagnostics Segment R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 70: Siemens Healthcare GmbH General and Administration Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 71: Siemens Healthcare GmbH Diagnostics Business Segment, Breakdown of Net Sales (%), by Region, 2017
Figure 72: Siemens Healthcare GmbH Diagnostics Business Segment, Breakdown of Net Sales (%), by Business Segment, 2017
Figure 73: bioMérieux SA Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 74: bioMérieux SA R & D Expenses (US$ Bn), 2015-2017
Figure 75: bioMérieux SA Breakdown of Net Sales, by Region, 2017
Figure 76: bioMérieux SA Breakdown of Net Sales, by Segment, 2017
Figure 77: Danaher Corporation Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2017
Figure 78: Danaher Corporation R & D Expenses
Figure 79: Danaher Corporation Breakdown of Net Sales, by Region, 2017
Figure 80: Danaher Corporation Breakdown of Net Sales, by Segment, 2017
Figure 81: Agilent Technologies Breakdown of Net Sales, by Segment, 2017
Figure 82: Agilent Technologies Breakdown of Net Sales, by Region, 2017
Figure 83: Agilent Technologies Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Pcr Technologies